Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
12:00 AM - 29th ECCMID
14
16
17
18
19
20
21
22
23
25
26
27
29
30
1
2
3
4
5
29th ECCMID
2019-04-13 - 2019-04-16    
All Day
Welcome to ECCMID 2019! We invite you to the 29th European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Amsterdam, Netherlands, [...]
4th International Conference on  General Practice & Primary Care
2019-04-15 - 2019-04-16    
All Day
The 4th International Conference on General Practice & Primary Care going to be held at April 15-16, 2019 Berlin, Germany. Designation Statement The theme of [...]
Digital Health Conference 2019
2019-04-24 - 2019-04-25    
12:00 am
An Innovative Bridging for Modern Healthcare About Hosting Organization: conference series llc ltd |Conference Series llc ltd Houston USA| April 24-25,2019 Conference series llc ltd, [...]
International Conference on  Digital Health
2019-04-24 - 2019-04-25    
All Day
Details of Digital Health 2019 conference in USA : Conference Name                              [...]
16th Annual World Health Care Congress -WHCC19
2019-04-28 - 2019-05-01    
All Day
16th Annual World Health Care Congress will be organized during April 28 - May 1, 2019 at Washington, DC Who Attends Hospitals, Health Systems, & [...]
Events on 2019-04-13
29th ECCMID
13 Apr 19
Amsterdam
Events on 2019-04-24
Events on 2019-04-28
Latest News

Modern Healthcare Thyme Care CVS Humana Partnership

EMR industry

Thyme Care Secures $97M Funding from CVS Health Ventures and Humana

Cancer care navigation startup Thyme Care announced Thursday that it has raised $97 million in a Series D funding round.

Thyme Care, a Nashville-based company specializing in value-based cancer care navigation, has secured $97 million in Series D funding, bringing its total capital raised to $275 million. The investment round was led by existing investors including CVS Health Ventures, Foresite Capital, a16z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp, and Frist Cressey Ventures. New strategic investors such as Morgan Health, Humana, Texas Oncology, and Memorial Hermann Health System also participated, elevating Thyme Care’s valuation to over $1 billion

Founded in 2020, Thyme Care aims to address the complexities of cancer care by providing integrated navigation services that reduce administrative burdens, support value-based drug choices, and enhance clinical collaboration. The company partners with over 1,000 oncologists nationwide and has expanded its reach to 8 million people, managing more than $5 billion in oncology spending

The recent funding will enable Thyme Care to scale its AI-powered infrastructure, focusing on areas such as treatment denials, high drug costs, and delayed access to care. The company plans to enhance its technology platform, develop member-facing applications, and expand partnerships with national and local health plans

Humana’s collaboration with Thyme Care, initiated in February 2025, provides eligible Medicare Advantage members in select states with 24/7 virtual care navigation, data-driven insights, and access to a dedicated care team. This partnership aims to minimize care gaps, reduce unnecessary expenditures, and support patients in managing the complexities of cancer care

Thyme Care’s integrated approach, combining technology, data analytics, and personalized support, positions it as a leader in transforming cancer care delivery. The company’s model aligns incentives across the oncology ecosystem, including payers, providers, and employers, to improve patient outcomes and reduce overall healthcare costs.